Teva Pharmaceutical Industries Ltd. — Report Publication Announcement 2008

Jul 14, 2008

_________ false

C002��� ������ ��������� ��"�2PublicTEVA- PHARMACEUTICAL INDUSTRIES LTD.2530Corporation no: 520013954Stock Exchange/Market: ���310380P.O.B 3190 , Petach Tikva 49131 , ,Tel: 03-9267554 , 03-9267652 Fax: 03-9267519E.mail address: elana.holzman@teva.co.ilDate of transmission: 14/07/2008              Time of broadcast: 12:23 12:11:10

Reference: 2008-02-201618

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on ADAGIO Phase III Top Line Data to be Presented at 12th Congress of European Federation of Neurological Societies -- First Prospective Study to Demonstrate Slowing of Parkinson�s Disease Progression with AZILECT�--
adagioefnsfina140708l_isa.pdf

Attached please find a press release issued July 14, 2008 in the U.S.
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure: 30/04/2008
- - -
Name of the Signatory: : Karniel Uzi , Position of Signatory in the reporting corporation: General Counsel & Company Secretary , Name of Employer Company: .
Basel Telephone: 03-9267297 , Facsimile: 03-9267429 , E-mail: uzi.karniel@teva.co.il 1